Biochemistry Division, Defence Research & Development Establishment (DRDE), Gwalior, MP 474002, India.
Defence Research & Development Establishment (DRDE), Gwalior, MP 474002, India.
Toxicol Sci. 2017 Nov 1;160(1):136-149. doi: 10.1093/toxsci/kfx162.
Sarin is an organophosphorus (OP) chemical warfare agent which irreversibly inhibits acetylcholinesterase. Acute toxicity after sarin exposure is because of hyper activation of the nicotinic and muscarinic receptor. Survivors of sarin exposure often develop long-term neuropathology referred as OP ester-induced chronic neurotoxicity. However, the exact mechanism of chronic neurotoxicity is yet unknown. We studied proteomic changes in rat brain regions after 0.5 LD50 dose of sarin and investigated some milestone changes associated with long-term CNS injury. We used two-dimensional gel electrophoresis/mass spectrometry approach to identify early proteomic changes and traced expression of selected proteins for longer time points. This study shows changes in chaperone function, endoplasmic reticulum stress, and defect in cytoskeleton functions at earlier stages. Predictive interaction analysis demonstrated putative role of Parkinson's disease-related proteins after sarin exposure. Our results clearly indicated neurodegenerative changes which started after 2.5 h and showed prominence after 3-month postexposure. The study also unmasks changes in proteins related to movement and cognitive function. The markers for astrocytosis (GFAP) and neurodegenerative changes (alpha-synuclein and amyloid precursor protein) exhibited altered expression in brain. This is the first proteomic study among survivors of sarin exposure in animal model. Some of the early changes, including those involved in neurodegeneration, movement, and cognitive function, defects in chaperone function and cytoskeleton, were shown to persist for a longer period. The study provides a preliminary framework for further validation of major mechanisms of sarin toxicity is suggested here and opens new avenues for elucidation of therapeutic intervention.
沙林是一种有机磷(OP)化学战剂,它会不可逆地抑制乙酰胆碱酯酶。沙林暴露后的急性毒性是由于烟碱和毒蕈碱受体的过度激活。沙林暴露的幸存者经常会发展出长期的神经病理学,称为 OP 酯诱导的慢性神经毒性。然而,慢性神经毒性的确切机制尚不清楚。我们研究了沙林 0.5LD50 剂量暴露后大鼠脑区的蛋白质组变化,并研究了与长期中枢神经系统损伤相关的一些里程碑式变化。我们使用二维凝胶电泳/质谱法来识别早期蛋白质组变化,并跟踪选定蛋白质的表达更长时间点。这项研究表明,在早期阶段,伴侣蛋白功能、内质网应激和细胞骨架功能缺陷发生变化。预测相互作用分析表明,沙林暴露后帕金森病相关蛋白可能发挥作用。我们的研究结果清楚地表明,神经退行性变化始于暴露后 2.5 小时,并在暴露后 3 个月后表现明显。该研究还揭示了与运动和认知功能相关的蛋白质变化。星形胶质细胞(GFAP)和神经退行性变化(α-突触核蛋白和淀粉样前体蛋白)的标志物在大脑中表现出改变的表达。这是在动物模型中对沙林幸存者进行的首次蛋白质组学研究。一些早期变化,包括涉及神经退行性变、运动和认知功能、伴侣蛋白功能和细胞骨架缺陷的变化,被证明会持续更长时间。该研究为进一步验证沙林毒性的主要机制提供了初步框架,并为阐明治疗干预措施开辟了新的途径。